Callitas Health Enters into Exclusive Development and Intellectual Property Agreement for CannaMint Strips and Files Additional Trademarks for CannaStrips and CanRelief
24 mai 2018 08h30 HE
|
Callitas Health Inc.
CINCINNATI, OH, May 24, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and...
Callitas Health Signs Dr. Gregory Smith MD, MPH, as the Company's Chief Medical Cannabis Advisor
21 mai 2018 10h55 HE
|
Callitas Health Inc.
CINCINNATI, OH, May 21, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE:LILY) (OTCQB:MPHMF) (FWB:T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and...